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Abstract
Purpose Disease-specific measures of the impact of
sacroiliac (SI) joint pain on back/pelvis function are not
available. The Oswestry Disability Index (ODI) is a vali-
dated functional measure for lower back pain, but its
responsiveness to SI joint treatment has yet to be estab-
lished. We sought to assess the validity of ODI to capture
disability caused by SI joint pain and the minimum clini-
cally important difference (MCID) after SI joint treatment.
Methods Patients (n = 155) participating in a prospective
clinical trial of minimally invasive SI joint fusion under-
went baseline and follow-up assessments using ODI, visual
analog scale (VAS) pain assessment, Short Form 36 (SF-
36), EuroQoL-5D, and questions (at follow-up only)
regarding satisfaction with the SI joint fusion and whether
the patient would have the fusion surgery again. All out-
comes were compared from baseline to 12 months post-
surgery. The health transition item of the SF-36 and the
satisfaction scale were used as external anchors to calculate
MCID. MCID was estimated for ODI using four calcula-
tion methods: (1) minimum detectable change, (2) average
ODI change of patients’ subsets, (3) change difference
between patients’ subsets, and (4) receiver operating
characteristic (ROC) curve.
Results After SI fusion, patients improved significantly
(p\ .0001) on all measures: SI joint pain (48.8 points),
ODI (23.8 points), EQ-5D (0.29 points), EQ-5D VAS (11.7
points), PCS (8.9 points), and MCS (9.2 points). The
improvement in ODI was significantly correlated
(p\ .0001) with SI joint pain improvement (r = .48) and
with the two external anchors: SF-36 health transition item
(r = .49) and satisfaction level (r = .34). The MCID val-
ues calculated for ODI using the various methods ranged
from 3.5 to 19.5 points. The ODI minimum detectable
change was 15.5 with the health transition item as the
anchor and 13.5 with the satisfaction scale as the anchor.
Conclusions ODI is a valid measure of change in SI joint
health. Hence, researchers and clinicians may rely on ODI
scores to measure disability caused by SI pain. We esti-
mated the MCID for ODI to be 13–15 points, which falls
within the range of that previously reported for lumbar
back pain and indicates that an improvement in disability
should be at least 15 % to be beyond random variation.
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Introduction
Chronic lower back pain (LBP) carries a significant public
health burden, with an estimated 83 million healthy years
of life lost every year due to illness, disability, or early
death [1]. In highly developed countries, lower back pain is
one of the top three causes of disability years, and the
disutility of chronic LBP has been rated as high in most
countries [2]. While the sacroiliac (SI) joint has been
identified as a source of pain for over a century, the extent
of the contribution of SI pain to low back pain has only
been recently recognized. In two large retrospective
reviews of patients referred for outpatient evaluation of
back pain, SI joint pain was a common diagnosis, occurring
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in 14 and 25 % of cases, respectively [3, 4]. Among
patients evaluated for residual off-center lower back pain
after lumbar fusion, the SI joint was diagnosed as the
source of pain in approximately 40 % of patients [5, 6].
Hippocrates was reported to have noted that the SI joint
is mobile during pregnancy. Pain emanating from the SI
joint was first described in the early 1900s [7], prior to
reports of pain emanating from the spine. The SI joint is
richly innervated [8], and studies of normal volunteers have
shown that local anesthetic injection into the SI joint can
eliminate pain provoked by probing of the ligaments sur-
rounding the joint or injections into the joint [9]. Pathways
between the SI joint and adjacent neural structures have
been identified [10]. The multiple innervation of the SI
joint complex has been studied in detail; anesthetic injec-
tions of sacral nerve roots only partially block pain elicited
during distention of the joint itself [11]. Patients with
clinical signs and symptoms suggestive of SI joint pain
commonly have reductions in pain with anesthetic injec-
tions [12], and this technique has become accepted by
numerous medical societies as a confirmatory diagnostic
test [13–17].
Treatment options for SI joint pain include physical
therapy [18], intra-articular steroid injections [19, 20], RF
ablation [21, 22], and open [23] or minimally invasive [24–
28] fusion. Evidence for the effectiveness physical therapy
is extremely limited, with no published clinical trials in a
general population of patients with SI joint conditions.
Although two randomized trials provide modest evidence
for short-term pain relief of peri-articular steroid injections
[19, 20], SI joint steroid injections provided in the US are
typically intra-articular.
Disability caused by both lumbar spine and SI joint pain
may be assessed with the Oswestry Disability Index (ODI).
First reported in 1980, the ODI is a validated and well-
accepted measure of the impact of lower back pain on
disability [29–31]. ODI does not appear to distinguish
between different causes of back pain. While it could be
assumed that the disability caused by SI joint pain is cap-
tured by ODI, this has not been established. Moreover,
whether ODI is a valid measure of disability caused by SI
joint pain is not known.
The minimum clinically important difference (MCID),
or the smallest change that is considered important to
patients, has been calculated for ODI for patients after
lumbar surgery, both in large samples of patients with
mixed diagnoses and surgical procedures and in small
samples with specific pathologies and surgeries. MCID
calculated for ODI ranges from 7 to 15 [32–35]. MCID is
useful as a threshold change to compare the effectiveness
of different surgical and non-surgical procedures for a
variety of conditions affecting the spine or pelvis.
The purpose of this study is to assess the validity of ODI
to capture disability caused by SI joint pain and its sensi-
tivity to change after treatment. The secondary purpose of
this study is to calculate the MCID for ODI following
minimally invasive SI joint fusion surgery using a
methodology similar to the methodology used to establish
MCID after lumbar surgery.
Materials and methods
An overview of the analytic methods is presented in
Table 1.
Patient selection and sample
Health-related quality-of-life (HRQoL) data for all calcu-
lations reported herein were derived from a cohort of
patients participating in Sacroiliac Joint Fusion Investiga-
tion (SIFI, NCT01640353) who completed the 12-month
postoperative visit. SIFI is a prospective, multicenter, sin-
gle-arm clinical trial of minimally invasive (MIS) SI joint
fusion using iFuse Implant System, an FDA-cleared
titanium porous-coated implant manufactured by the
study’s sponsor (SI-BONE, Inc., San Jose, CA, USA). The
study protocol was IRB-approved at all clinical sites prior
to patient enrollment.
SIFI participants were patients between the ages of 21
and 70 with a diagnosis of SI joint dysfunction due to
degenerative sacroiliitis and/or sacroiliac joint disruption.
Diagnosis was based on a combination of history of SI joint
pain with Fortin’s sign [36], at least three positive physical
examination signs predictive of SI joint pain [37], and at
least a 50 % decrease in pain after image-guided local
anesthetic injection into the SI joint within 3 months prior
to screening. Inclusion also required a baseline ODI score
of at least 30 % and an SI joint pain score of at least 50 on
a 0–100-mm visual analog scale (VAS).
Patients were excluded for a variety of conditions,
including severe back pain due to other causes (e.g., lum-
bar disk degeneration, spinal stenosis), history of recent
(\1 year) major trauma to the pelvis, metabolic bone dis-
ease (either induced or idiopathic), involvement in litiga-
tion, or receiving disability payments or worker’s
compensation for back or SI joint pain. Exclusion criteria
were designed to eliminate patients with other pathologies
that could be mistaken for SIJ pain. However, the study did
not exclude patients with prior lumbar fusion as this is a
risk factor for SI joint degeneration [38]. Early study
results have been reported [28]. More recently, results from
a companion randomized trial with identical eligibility
criteria have been reported [39].
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Patients underwent minimally invasive SI joint fusion
(as described by Rudolf [24] and Sachs and Capobianco
[26]) within 30 days of their baseline assessment. Patients
were discharged home at the surgeon’s discretion and
returned to clinic at 1, 3, 6, and 12 months postoperatively.
Outcome measures
As described previously [28], baseline assessments inclu-
ded a detailed medical history, physical examination, and
quality-of-life questionnaires including ODI [30], Euro-
QoL-5D (EQ-5D) [40], and Short Form 36 (SF-36) [41].
ODI is a brief, 10-question survey that assesses the impact
of pain on daily life activities such as personal care, lifting,
walking, sitting, standing, sleeping, sex life, social life, and
traveling. Scores range from 0 to 100 % disability. ODI is
probably the most commonly used patient-reported out-
come in studies of patients with spinal pain and is accepted
as a type of gold standard. Two types of pain were assessed
(SI joint pain and back pain), both using a 100-mm visual
analog scale (VAS) where 0 represents no pain and 100
represents worst pain imaginable. Patients were instructed
to differentiate SI joint pain from back pain. Patients had
been suffering from chronic SI joint pain for many years
and were very familiar with their condition. Patients who
suffered from both SI joint and back pain had been
informed as to what kind of pain could be expected to
improve with SI joint fusion.
At both the 6- and 12-month visits, patients were asked
to rate their level of satisfaction with surgery (‘‘very dis-
satisfied,’’ ‘‘somewhat dissatisfied,’’ ‘‘somewhat satisfied,’’
or ‘‘very satisfied’’) and willingness to undergo the
procedure again (‘‘would definitely not have surgery again
for same condition,’’ ‘‘might have surgery again for same
condition,’’ ‘‘would definitely have surgery again for same
condition’’). These last two scales are very commonly used




All MCID analyses presented herein focus on 12-month
assessments and were performed with SPSS (version 22,
SPSS Inc., Chicago, IL). The changes from baseline in ODI
and VAS scores for SI joint pain were calculated as the
baseline score minus the 12-month score such that a pos-
itive change score corresponds to improvement. Baseline
and 12-month assessments were compared with a paired
sample t test. The relationship between demographic
characteristics and outcome measures was assessed with
Pearson’s correlation coefficient for numerical data and
Chi-square for categorical data. Analysis of variance was
used to compare the change in outcomes according to the
subjects’ answers to the health transition item (HTI) of the
SF-36 and to the satisfaction scale.
MCID calculations
Two measures were selected as global assessments of
change and as proxy for objective measures of change (i.e.,
as external anchors): the HTI of the SF-36 and the previ-
ously mentioned satisfaction with surgery scale [32]. The
Table 1 Overview of analyses
ODI sensitivity to SI pain Calculation of MCID of ODI for SI pain treatment
Based on the whole sample. Patients with and without prior
lumbar fusion were combined after confirming the absence of
statistical difference between the two groups (Table 2)
Overall treatment results: preoperative and postoperative
scores for (Table 3)




(e) Satisfaction with outcomes of surgery scale
(f) Willingness to undergo surgery again scale
ODI sensitivity to SI pain. Correlation between change in SI




Based on two subsets of patients selected according to their
answers to two anchors
(a) The heath transition item (HTI) of the SF-36
(b) The satisfaction with surgery scale
Correlation between change in ODI and (Table 5; Fig. 1)
(a) HTI
(b) Satisfaction scale
MCID calculations. Selection (Table 6) and comparison of
patients who reported no change/no satisfaction to patients
who reported small change/small satisfaction. These subsets
of patients are used for four MCID calculations (Table 7)
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HTI is part of the SF-36, but is not used to calculate its
scales nor summary measures [42]. In accordance with the
conceptualization of MCID as a small but important
change, patients at adjacent levels of the scales were
selected for the MCID calculations. The HTI asks subjects
to compare their current health to their health 1 year ago.
Possible answers were ‘‘much better,’’ ‘‘somewhat better,’’
‘‘about the same,’’ ‘‘somewhat worse,’’ and ‘‘much worse.’’
Patients who answered ‘‘somewhat better’’ or ‘‘about the
same’’ were selected. When using the satisfaction scale as
the anchor, patients who answered ‘‘somewhat satisfied’’ or
‘‘somewhat dissatisfied’’ were selected.
Four calculations were used to determine possible val-
ues for MCID [32].
1. The minimum detectable change (MDC), i.e., the
smallest change that can be considered above mea-
surement error with 95 % confidence. MDC was
calculated as:
MDC = 1.96 9
ﬃﬃﬃ
2
p  SEM, where SEM is the stan-
dard error of measurement calculated as
SEM ¼ SD ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 rp . SD is the standard deviation
of the baseline scores, and r is the test–retest reliability
coefficient [43–45]. A reliability of 0.9 was used for
ODI [46].
2. The average change, i.e., the average score change
seen in ‘‘somewhat better’’ patients (for the HTI) and
the ‘‘somewhat satisfied’’ patients (for the satisfaction
scale).
3. The change difference, i.e., the difference between the
average change scores of the ‘‘somewhat better’’ and
‘‘about the same’’ patients (HTI) and the ‘‘somewhat
satisfied’’ and ‘‘somewhat dissatisfied’’ patients (satis-
faction scale).
4. The ROC curve approach, where MCID is the change
score that differentiates between the ‘‘somewhat bet-
ter’’ and ‘‘about the same’’ patients (HTI) and the
‘‘somewhat dissatisfied’’ and ‘‘somewhat satisfied’’
patients (satisfaction scale) with identical sensitivity
and specificity.
Results
Of 172 enrolled subjects at 26 centers, 155 (90.1 %) who
completed the 12-month visit comprise the study cohort.
Mean (SD) age was 51.5 (11.1) years, and BMI was 29.4
(6.4) kg/m2. Most subjects were women (71.0 %), and
24.5 % were smokers. Subjects had suffered from SI joint
pain for an average of 5.4 (6.5) years; 43 % had undergone
lumbar spinal fusion, a suspected risk factor for SI joint
degeneration [38]. Both baseline scores and change scores
(baseline to 12-month visit) were not statistically different
between subjects with and without prior lumbar fusion
(Table 2). Hence, the two groups of patients were com-
bined in all analyses.
Overall treatment outcomes
Consistent with other reports of minimally invasive SIJ
fusion, SI joint pain and all HRQoL ratings assessed in the
SIFI study showed significant improvement from baseline
to 12-month postoperative scores (Table 3). Baseline ODI
was moderately correlated with baseline SI joint pain
(Pearson r = 0.21, p = .0097). However, no commonly
assessed demographic characteristics (age, BMI, SI pain
duration, prior lumbar fusion, smoking status, diagnosis,
Table 2 Outcome scores of patients with and without prior lumbar fusion: mean (SD)
Patients with prior lumbar
fusion (n = 67)
Patients without prior
lumbar fusion (n = 88)
p value*
Baseline ODI 55.5 (10.2) 55.3 (11.8) .914
ODI change baseline to 12 months 21.5 (19.2) 25.5 (21.4) .231
Baseline SIJ pain 77.6 (13.2) 80.5 (12.9) .180
SIJ pain change baseline to 12 months 44.5 (29.4) 52.1 (29.2) .1154
Baseline EQ-5D .449 (.173) .427 (.181) .447
EQ-5D change baseline to 12 months .277 (.232) .300 (.250) .579
Baseline EQ-5D VAS 57.5 (24.2) 56.8 (23.3) .845
EQ-5D VAS change baseline to 12 months 10.6 (30.7) 12.5 (25.6) .674
Baseline PCS of the SF-36 30.9 (5.0) 32.1 (5.8) .153
PCS change baseline to 12 months 8.6 (8.6) 9.1 (10.7) .745
Baseline MCS of the SF-36 39.0 (11.8) 38.6 (10.4) .839
MCS change baseline to 12 months 9.0 (12.3) 9.4 (11.4) .831
* Comparison across groups with and without lumbar fusion
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and gender) were statistically associated with either base-
line SIJ pain scores or ODI or the 12-month change scores.
As expected, baseline ODI was correlated with the
12-month ODI change score (r = 0.38, p\ .0001), indi-
cating that subjects with a higher baseline disability tended
to have a greater improvement.
ODI Sensitivity to SI pain change
The 12-month ODI change score was strongly correlated
with the change in SI joint pain (Table 4), indicating that
ODI is sensitive to SI joint pain change.
MCID
As described in methods, MCID calculations involve cor-
relating the target measure (ODI) with various parameters
of global change. ODI change score was statistically
associated with the HTI (r = .49, p\ .0001), the satis-
faction scale (r = .34, p\ .0001), and the willingness to
undergo surgery again scale (r = .32, p = .0001) (Fig. 1).
Table 5 reports the ODI score change according to sub-
jects’ answers to the HTI and the satisfaction scale, the two
scales retained as anchors. The average ODI change score
was significantly different across the answers to the two
scales (p\ .0001). The correlation between changes in
ODI, HTI, and satisfaction, as well as the fact that ODI
change is different between the answers of the scales,
indicates that the HTI and satisfaction scales are reasonable
anchors [47].
Baseline scores and demographic characteristics of the
four subsets of patients selected for the MCID analysis are
reported in Table 6. There were no statistically significant
differences in these characteristics between subjects
reporting ‘‘somewhat dissatisfied’’ and those reporting
‘‘somewhat satisfied.’’ The only statistically significant
difference between the ‘‘about the same’’ and the ‘‘some-
what better’’ patients was the duration of pain prior to
surgery.
The four methods used to calculate MCID yielded the
values summarized in Table 7. As expected, each method
yielded a different value for MCID: from 6.3 to 19.5 with
the HTI as anchor and from 3.5 to 13.5 with the satisfaction
scale as anchor. The range of MCID values was consistent
across the HTI and the satisfaction scale.
Discussion
Outcome measures of disability caused by back pain are
key in assessing the effectiveness of surgical and non-
surgical treatment options as well as in comparing treat-
ment-associated risks and benefits. ODI is a well-accepted
measurement of disability in patients with back pain and
has been used in hundreds of studies [30]. However,
patients with SI joint pathology may have pain syndromes
in the low back, pelvis, buttock, and groin that are different
from those with more common lumbar spine pain. More-
over, disability in this population may occur during activ-
ities different from those asked on the ODI instrument.
Thus, it is relevant to determine whether ODI is valid for
measuring disability due to SI joint pain.
Subjects in this study formed a homogenous set of
carefully diagnosed patients who participated in a rigorous
prospective multicenter clinical trial. This sample showed a
large, clinically important improvement in both ODI and SI
joint pain at 12 months after fusion surgery. The
improvement in ODI was significantly correlated with the
improvement of SI joint pain, indicating that ODI ade-
quately captures the disability (and improvement thereof)
caused by SI joint pain. The ODI change score also showed
a graded relationship to the three measures of patient global
assessment of the outcome of the surgery: SF-36 HTI,
satisfaction, and willingness to undergo surgery again
(Fig. 1).
Substantial research has been performed to determine
the change in ODI that corresponds to the MCID for
patients undergoing a wide variety of spine surgeries.
These efforts have produced a variety of values purported
to represent the smallest improvement that patients con-
sider important. The secondary purpose of the present
Table 3 Baseline and 12-month outcome scores: mean (SD)
Baseline 12 months p value* Change score
ODI 55.4 (11.1) 31.6 (19.3) \.0001 23.8 (20.5)
SI joint pain 79.3 (13.1) 30.6 (27.6) \.0001 48.8 (29.4)
EQ-5D .438 (.179) .710 (.198) \.0001 .290 (.242)
EQ-5D VAS 57.1 (23.7) 68.7 (20.7) \.0001 11.7 (27.8)
PCS 31.6 (5.5) 40.4 (9.5) \.0001 8.9 (9.8)
MCS 38.8 (11.0) 48.0 (12.4) \.0001 9.2 (11.7)
* Difference from baseline to 12 months postoperative





EQ-5D VAS .25 .002
PCS .44 \.001
MCS .21 .009
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study was to calculate MCID values to determine whether
MCID values for ODI after SI fusion are similar to those
seen after lumbar fusion. We purposefully replicated the
MCID calculation methods used for MCID after lumbar
surgeries and similarly used the SF-36 HTI and a satis-
faction scale as our two external anchors [32–35]. The best
method to estimate MCID is not universally agreed upon.
Often, the MDC is chosen to represent MCID because
MDC is the smallest value necessary to go beyond the
measurement error. While SI joint pain is a type of low
back pain, no study to date has investigated the use of ODI
specifically for SI pathology and treatment. Our data
indicate that ODI may be a valid measure for SI joint
disability and is sensitive to change in disability. Hence,
researchers and clinicians may rely on ODI scores to
measure disability caused by SI pain. According to MDC,
an improvement in disability as measured by ODI should
be at least 15 % to be beyond random variation.
To limit the possible heterogeneity that could arise due
to the participation of 26 clinical centers, the multicenter
study had strict and detailed eligibility criteria, including
specific factors in medical history, physical examination,
and confirmatory diagnostic testing. The testing required
for diagnosis of SIJ pain is more extensive than most other
orthopedic conditions, and the degree of testing required in
this study was beyond what is typically done in a standard
clinical setting.
Table 5 ODI change score by SF-36 health transition item and sat-
isfaction rating: mean (SD)
SF-36 health transition item N ODI***
Much better 66 35.5 (16.5)
Somewhat better 39 19.5 (16.2)
About the same 32 13.2 (18.9)
Somewhat worse 11 10.0 (25.7)
Much worse 4 9.7 (21.6)
Satisfaction rating N ODI***
Very satisfied 110 29.0 (19.8)
Somewhat satisfied 26 12.2 (12.1)
Somewhat dissatisfied 11 8.7 (21.7)
Very dissatisfied 5 13.9 (24.8)
Positive values indicate improvement
*** p\ .001 for the difference between the scale ratings
bFig. 1 Average ODI change score by SF-36 health transition item
(a), satisfaction scale (b), and desirability of having surgery again (c).
Each plot shows values at 6 months (left) and 12 months (right).
Positive values indicate improvement
Table 6 Baseline characteristics by 12-month SF-36 health transition item and satisfaction rating: mean (SD) or count (proportion)






dissatisfied (n = 11)
Somewhat
satisfied (n = 26)
p value*
Age 50.9 (12.0) 51.3 (9.0) .8885 51.0 (13.2) 50.2 (11.8) .8670
BMI 30.0 (7.9) 29.9 (5.4) .9547 26.5 (6.7) 31.0 (6.0) .0740
Pain duration 3.0 (3.1) 5.4 (5.0) .0188 3.7 (4.0) 6.0 (6.4) .2042
Female gender 24 (75.0 %) 25 (64.1 %) .4402 7 (63.6 %) 18 (69.2 %) 1.000
Prior lumbar fusion 12 (37.5 %) 18 (46.2 %) .4812 7 (63.6 %) 11 (42.3 %) .2953
Current smoker 10 (31.3 %) 6 (15.4 %) .2816 4 (36.4 %) 7 (26.9 %) .3721
Former smoker 8 (25.0 %) 12 (30.8 %) .2816 1 (9.1 %) 8 (30.8 %) .3721
Baseline ODI 56.5 (11.4) 54.1 (9.9) .3552 54.0 (11.8) 56.1 (9.2) .6037
Baseline SIJ pain 78.19 (11.8) 82.5 (10.9) .1173 75.0 (15.6) 77.9 (12.4) .5891
* Difference between the two subsets of patients
Table 7 MCID values of ODI after SI joint fusion as calculated by
four methods
SF-36 health transition Satisfaction
MDC (95 % CI) 15.5 13.5
Average change 19.5 12.2
Change difference 6.3 3.5
ROC curve (AUC) 15.0 (.629) 13.0 (.530)
MDC (95 % CI): minimum detectable change with 95 % confidence
interval. Average change: average change among ‘‘somewhat better’’
for the health transition or ‘‘somewhat satisfied’’ for the satisfaction
scale. Change difference: difference in the change of the ‘‘somewhat
better’’ versus ‘‘about the same’’ for the SF-36 health transition and
the ‘‘somewhat satisfied’’ and ‘‘somewhat dissatisfied’’ for the satis-
faction scale
ROC Curve receiver operating characteristics curve. AUC area under
the curve
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Another potential source of heterogeneity stems from
the fact that the patients have received different treatment
prior to the study, such as physical therapy and steroid
injections. There is little evidence that any of these thera-
pies provide relief from SI joint pain or disability, with the
exception of radio-frequency ablation [48], which few
patients had prior to the study.
Our study relied on a variety of HRQoL assessment
instruments. Each instrument is meant to capture a differ-
ent aspect of health, e.g., function/pain (ODI), pain (neck
and arm pain), physical health (PCS), mental health
(MCS), and general health (EQ-5D). Hence, it is not
expected that patients would report similar responses to
treatment on all HRQoL [49]. In the present study, patients
reported a statistically significant improvement on all
HRQoL measures. While all these HRQoL measures are
validated instruments, we chose to establish MCID
specifically for the ODI because the FDA requests the use
of a disease-specific pain and function measure, such as the
ODI [50], and because the ODI is used as a primary end-
point in most FDA-regulated spine trials.
This study collected only limited socioeconomic and
biopsychologic information and is, thus, unable to assess
the influence of these factors on the patients’ perception of
pain and responses to treatment. However, biopsychologic
and socioeconomic characteristics have been found to
influence patients’ perception of pain and response to and
choice of treatments in general and in the field of spine
surgery in particular [51–62].
Conclusions
ODI appears to be a valid instrument to measure disability
associated with SI joint pain. ODI is sensitive to the
changes in disability following MIS SI joint fusion. The
MCID values obtained for ODI after MIS SI joint fusion
are similar to the MCID values accepted for ODI after
lumbar surgeries.
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